337 related articles for article (PubMed ID: 2563293)
1. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
Hawkins KN; Knapp RJ; Lui GK; Gulya K; Kazmierski W; Wan YP; Pelton JT; Hruby VJ; Yamamura HI
J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293
[TBL] [Abstract][Full Text] [Related]
2. H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors.
Gulya K; Lui GK; Pelton JT; Kazmierski W; Hruby VJ; Yamamura HI
NIDA Res Monogr; 1986; 75():209-12. PubMed ID: 2893264
[TBL] [Abstract][Full Text] [Related]
3. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
Kramer TH; Shook JE; Kazmierski W; Ayres EA; Wire WS; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
[TBL] [Abstract][Full Text] [Related]
4. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
5. [D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin: a selective high affinity radioligand for delta opioid receptors with exceptional specific activity.
Knapp RJ; Sharma SD; Toth G; Duong MT; Fang L; Bogert CL; Weber SJ; Hunt M; Davis TP; Wamsley JK
J Pharmacol Exp Ther; 1991 Sep; 258(3):1077-83. PubMed ID: 1653834
[TBL] [Abstract][Full Text] [Related]
6. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
7. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
Shook JE; Pelton JT; Lemcke PK; Porreca F; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
Pelton JT; Kazmierski W; Gulya K; Yamamura HI; Hruby VJ
J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079
[TBL] [Abstract][Full Text] [Related]
9. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
Schoffelmeer AN; Warden G; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1991 Jul; 258(1):237-42. PubMed ID: 1677039
[TBL] [Abstract][Full Text] [Related]
10. Light microscopic autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog.
Gulya K; Gehlert DR; Wamsley JK; Mosberg H; Hruby VJ; Yamamura HI
J Pharmacol Exp Ther; 1986 Aug; 238(2):720-6. PubMed ID: 3016247
[TBL] [Abstract][Full Text] [Related]
11. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
Werling LL; Zarr GD; Brown SR; Cox BM
J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
[TBL] [Abstract][Full Text] [Related]
12. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine.
Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
J Pharmacol Exp Ther; 1997 Jan; 280(1):402-9. PubMed ID: 8996221
[TBL] [Abstract][Full Text] [Related]
14. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the binding of a morphine (mu) receptor-specific ligand: Tyr-Pro-NMePhe-D-Pro-NH2, [3H]-PL17.
Blanchard SG; Lee PH; Pugh WW; Hong JS; Chang KJ
Mol Pharmacol; 1987 Apr; 31(4):326-33. PubMed ID: 3033464
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mu opioid receptor binding on intact neuroblastoma cells with guinea pig brain and neuroblastoma cell membranes.
Toll L
J Pharmacol Exp Ther; 1992 Jan; 260(1):9-15. PubMed ID: 1346168
[TBL] [Abstract][Full Text] [Related]
18. Effect of ambient temperature on the ability of mu-, kappa- and delta-selective opioid agonists to modulate thermoregulatory mechanisms in the rat.
Handler CM; Piliero TC; Geller EB; Adler MW
J Pharmacol Exp Ther; 1994 Feb; 268(2):847-55. PubMed ID: 8113997
[TBL] [Abstract][Full Text] [Related]
19. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
20. Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors.
Gulya K; Pelton JT; Hruby VJ; Yamamura HI
Life Sci; 1986 Jun; 38(24):2221-9. PubMed ID: 2872570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
